Search for Clinical Trial Results
Hepatitis B, Chronic - 28 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study Condition: Hepatitis B, Chronic Date: 2014-07-17 Interventions: Drug: Tenofovir disoproxil fumarate Tenofovir disoproxil fumarate tablets supplied will be white, almond |
Completed |
Study Name: A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) Condition: Hepatitis B, Chronic Date: 2008-03-18 Interventions: Drug: Tenofovir All patients receive 600 mg/day, oral telbivudine for 24 weeks. Patients with non-detect |
Completed |
Study Name: Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir Condition: Hepatitis B, Chronic Date: 2009-12-01 Interventions:
|
Completed |
Study Name: KRN7000 in Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2006-08-10 Interventions: Drug: KRN7000 |
Completed |
Study Name: Long-Term Lamivudine Therapy for Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2005-07-15 Interventions:
|
Active, not recruiting |
Study Name: Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis Condition: Hepatitis B, Chronic Date: 2014-08-21 Interventions: Drug: Tenofovir disoproxil fumarate White, almond-shaped, film-coated tablet containing 300 mg of TDF, d |
Completed |
Study Name: Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 Condition:
|
Completed |
Study Name: PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327) Condition: Hepatitis B, Chronic Date: 2007-09-26 Interventions:
|
Enrolling by invitation |
Study Name: Use of TDF in Patients With Inactive Chronic Hepatitis B Infection Condition: Hepatitis B, Chronic Date: 2015-11-03 Interventions: Drug: Tenofovir disoproxil fumarate 300 mg, oral, once a day |
Completed |
Study Name: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B. Condition: Hepatitis B, Chronic Date: 2007-06-18 Interventions: Drug: peginterferon alfa-2a [Pegasys] 180 micrograms sc weekly for 48 weeks |